A clinical study evaluating the effect of eppikajutsuto on lymphatic malformations
Phase 2
- Conditions
- ymphatic malformation
- Registration Number
- JPRN-jRCTs041210007
- Lead Sponsor
- Ogawa Keiko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1. Diagunostic image (at least Echo,CT,MRI)demonstrates a specific LM lesion
2. Weight 25kg or less
Exclusion Criteria
When any one or more of the following items are satisfied
Has a history of allergic reactions to Eppikajutsuto.
Have received or have received mTOR inhibitors
Has undergone sclerotherapy / surgery in the past
Has a serious disease other than lymphatic malformation
Participated in other clinical studies (studies) within 3 months before the start of administration of the test drug
Evaluable MRI cannot be taken
When the principal investigator or the investigator determines that apatients is inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method